Haematopoietic stem cell gene therapy with IL‐1Ra rescues cognitive loss in mucopolysaccharidosis IIIA

Mucopolysaccharidosis IIIA is a neuronopathic lysosomal storage disease, characterised by heparan sulphate and other substrates accumulating in the brain. Patients develop behavioural disturbances and cognitive decline, a possible consequence of neuroinflammation and abnormal substrate accumulation....

Descripción completa

Detalles Bibliográficos
Autores principales: Parker, Helen, Ellison, Stuart M, Holley, Rebecca J, O'Leary, Claire, Liao, Aiyin, Asadi, Jalal, Glover, Emily, Ghosh, Arunabha, Jones, Simon, Wilkinson, Fiona L, Brough, David, Pinteaux, Emmanuel, Boutin, Hervé, Bigger, Brian W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7059006/
https://www.ncbi.nlm.nih.gov/pubmed/32057196
http://dx.doi.org/10.15252/emmm.201911185

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7059006/
https://www.ncbi.nlm.nih.gov/pubmed/32057196
http://dx.doi.org/10.15252/emmm.201911185

Ejemplares similares